
Keywords: AA-PEG; aminoethylanisamide-polyethylene glycol; AD; Alzheimer's disease; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; CML; Chronic Myeloid Leukemia; CPPs; cell penetrating peptides; c(RGDyK; cyclo(Arg-Gly-Asp-D-Tyr-Lys) peptide; DSP